BCL6-IN-3 (example 20a) is a B-cell lymphoma 6 (BCL6) inhibitor with anti-tumor activity, extracted from patent WO2018215801A1. BCL6-IN-3 (example 20a) exhibits a GI50 of 70 nM in SU-DHL4 cells. References: [1]. Benjamin Richard, et al. BENZIMIDAZOLONE DERIVED INHIBITORS OF BCL6. Patent. WO2018215801A1.

纯度：≥98%

CAS：2253878-44-1